Latest evidence-based view
FDT · HOLD
FDT (First Trust Developed Markets ex-US…) reweights stocks by momentum, quality, value or another systematic factor. One-month (+9.72%) and three-month (-4.50%) evidence is not decisive enough for a directional call.
FDT currently supports a wait stance.
One-month (+9.72%) and three-month (-4.50%) evidence is not decisive enough for a directional call.
The opposing case is clear: a factor regime change can cause prolonged relative underperformance. the 0.80% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.